| 产品描述: | 丙戊酸(VPA)衍生物,可在体内迅速水解为VPA;a valproic acid (VPA) derivative that is hydrolyzed rapidlyin vivoto VPA;丙戊酸(VPA)的衍生物,用作抗癫痫药。它在体内迅速水解成VPA,但具有固有的抗惊厥活性。;A derivative of Valproic acid (VPA) and is employed as an antiepileptic drug. It is hydrolyzed quickly to VPA in vivo, but has intrinsic anticonvulsant activity. |
| 体内研究: |
Valpromide (3 mmol/kg; 皮下注射; 单次给药) 在 NMRI 小鼠中,其诱导的露脑畸形率远低于丙戊酸 。 |
| 参考文献: |
1. Gorres KL, et al. Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus. MBio. 2016 Mar 1;7(2):e00113. 2. Pacifici GM, et al. Valpromide inhibits human epoxide hydrolase. Br J Clin Pharmacol. 1986 Sep;22(3):269-74. 3. Radatz M, et al. Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid. Epilepsy Res. 1998 Mar;30(1):41-8. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
6.982 ml |
34.909 ml |
69.818 ml |
| 5 mM |
1.396 ml |
6.982 ml |
13.964 ml |
| 10 mM |
0.698 ml |
3.491 ml |
6.982 ml |
| 50 mM |
0.14 ml |
0.698 ml |
1.396 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |